| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SPDR SER TR | 130,000 | 9,014,000 | 6.69% | ||
| 2 | ISHARES TR | 25,000 | 7,332,000 | 5.44% | ||
| 3 | MERCK & CO INC | 83,700 | 5,318,000 | 3.95% | ||
| 4 | ALKERMES PLC | 84,190 | 4,925,000 | 3.66% | ||
| 5 | BRISTOL MYERS SQUIBB CO | 90,000 | 4,894,000 | 3.63% | ||
| 6 | INCYTE CORP | 35,240 | 4,711,000 | 3.50% | ||
| 7 | ALNYLAM PHARMACEUTICALS INC | 90,121 | 4,619,000 | 3.43% | ||
| 8 | NEKTAR THERAPEUTICS COM | 186,287 | 4,372,000 | 3.24% | ||
| 9 | SEATTLE GENETICS INC | 69,512 | 4,370,000 | 3.24% | ||
| 10 | ALEXION PHARMACEUTIC | 35,000 | 4,244,000 | 3.15% | Call | |
| 11 | PROSHARES TR | 85,000 | 4,102,000 | 3.04% | ||
| 12 | PFIZER INC | 112,300 | 3,842,000 | 2.85% | ||
| 13 | ASTRAZENECA PLC | 120,000 | 3,737,000 | 2.77% | ||
| 14 | VERTEX PHARMACEUTICALS INC | 34,006 | 3,719,000 | 2.76% | ||
| 15 | CELGENE CORP | 28,197 | 3,509,000 | 2.60% | ||
| 16 | METTLER-TOLEDO | 7,188 | 3,442,000 | 2.55% | ||
| 17 | AGIOS PHARMACEUTICALS INC | 57,410 | 3,353,000 | 2.49% | ||
| 18 | ILLUMINA INC | 19,432 | 3,316,000 | 2.46% | ||
| 19 | QIAGEN NV | 111,763 | 3,238,000 | 2.40% | ||
| 20 | AMGEN INC | 19,401 | 3,183,000 | 2.36% | ||
| 21 | IONIS PHARMACEUTICALS INC COM | 78,900 | 3,172,000 | 2.35% | ||
| 22 | BIOGEN INC | 11,404 | 3,118,000 | 2.31% | ||
| 23 | REGENERON PHARMACEUTICALS | 8,035 | 3,114,000 | 2.31% | ||
| 24 | BIOMARIN PHARMACEUTICAL INC | 32,911 | 2,889,000 | 2.14% | ||
| 25 | GLAXOSMITHKLINE PLC | 60,000 | 2,530,000 | 1.88% | ||
| 26 | BRISTOL MYERS SQUIBB CO | 45,000 | 2,447,000 | 1.82% | Call | |
| 27 | PACIRA PHARMACEUTICALS INC | 50,000 | 2,280,000 | 1.69% | ||
| 28 | ALEXION PHARMACEUTIC | 18,701 | 2,267,000 | 1.68% | ||
| 29 | CLOVIS ONCOLOGY INC | 30,000 | 1,910,000 | 1.42% | ||
| 30 | PARATEK PHARMACEUTICALS INC | 80,000 | 1,540,000 | 1.14% | ||
| 31 | TESARO INCORPORATED | 10,000 | 1,539,000 | 1.14% | ||
| 32 | MEDICINES CO | 28,000 | 1,369,000 | 1.02% | ||
| 33 | LILLY ELI & CO | 15,000 | 1,262,000 | 0.94% | Call | |
| 34 | ADAMAS PHARMACEUTICALS INC | 60,000 | 1,050,000 | 0.78% | ||
| 35 | AXSOME THERAPEUTICS INC COM | 267,000 | 1,041,000 | 0.77% | ||
| 36 | PORTOLA PHARMACEUTICALS INC | 25,000 | 980,000 | 0.73% | ||
| 37 | NEW SR INVEST GRP INC COM | 83,700 | 854,000 | 0.63% | ||
| 38 | ULTRAGENYX PHARMACEUTICAL INC COM | 12,201 | 827,000 | 0.61% | ||
| 39 | GILEAD SCIENCES INC | 10,000 | 679,000 | 0.50% | Call | |
| 40 | CONTRAFECT CORP COM | 300,000 | 540,000 | 0.40% | ||
| 41 | HERON THERAPEUTICS INC COM | 31,748 | 476,000 | 0.35% | ||
| 42 | KITE PHARMA INCORPORATED | 5,931 | 466,000 | 0.35% | ||
| 43 | SOCIETAL CDMO INC | 50,463 | 441,000 | 0.33% | ||
| 44 | DIREXION PORTFOLIOPLUS SP BIOTCH BL NEW ETF | 8,723 | 416,000 | 0.31% | ||
| 45 | GRIFOLS S A SP ADR REP B | 21,932 | 414,000 | 0.31% | ||
| 46 | Progenics Pharmaceuticals Inc | 43,565 | 411,000 | 0.31% | ||
| 47 | QUINTILES IMS HOLDINGS INC | 5,027 | 405,000 | 0.30% | ||
| 48 | JUNO THERAPEUTICS INC COM | 18,030 | 400,000 | 0.30% | ||
| 49 | CHARLES RIV LABS INTL INC | 4,441 | 399,000 | 0.30% | ||
| 50 | NEUROCRINE BIOSCIE COM USD0.001 | 9,184 | 398,000 | 0.30% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001387131-17-002785, filed 2017.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
